Home > Search Results: Secukinumab
  Search Tips
Advanced Search
Search collections:
Sort by: Display results: Output format:
Results overview: Found 3 records in 0.03 seconds.
Articles, 3 records found
Articles 3 records found  
1.
20 p, 724.5 KB From messengers to receptors in psoriasis : The role of il-17ra in disease and treatment / Vidal, Silvia (Institut d'Investigació Biomèdica Sant Pau) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; González-Cantero, Á. (Psoriasis and Inflammatory Skin Diseases Unit. Grupo Pedro Jaen) ; Ruiz-Carrascosa, J.C. (Hospital Universitario San Cecilio (Granada)) ; Velasco-Pastor, A.M. (Hospital Arnau de Vilanova (València))
The paradigm of psoriasis as a Th17-driven disease has evolved in the last years towards a much deeper knowledge of the complex pathways, mechanisms, cells, and messengers involved, highlighting the crucial role played by the IL-17 family of cytokines. [...]
2021 - 10.3390/ijms22136740
International journal of molecular sciences, Vol. 22 Núm. 13 (january 2021) , p. 6740  
Detailed record - Creative Commons
2.
1 p, 338.7 KB Erratum to : Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials / Adsit, Sandra (TCR Medical Corporation) ; Zaldivar, Enrique Rivas (Dermos, Guatemala City, Guatemala) ; Sofen, Howard (Los Angeles, CA USA) ; Dei-Cas, Ignacio (Halitus, Buenos Aires, Argentina) ; Maldonado-García, César (Centro Dermatológico "Dr. Ladislao de la Pascua", Mexico City, Mexico) ; Peñaranda, Elkin O. (Riesgo de Fractura S.A., Bogota, Colombia) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Meng, Xiangyi (East Hanover, NJ USA) ; Fox, Todd (Basel, Switzerland) ; Guana, Adriana (East Hanover, NJ USA) ; Universitat Autònoma de Barcelona
Introduction: There is little evidence available on the efficacy and safety of biologic therapies for the treatment of psoriasis in Hispanic patients. Secukinumab is demonstrated to be highly effective for clearing psoriasis. [...]
2017 - 10.1007/s12325-017-0563-2
Advances in Therapy, Vol. 34 (june 2017) , p. 1772  
Detailed record - Creative Commons
3.
13 p, 1.5 MB Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis : Pooled Analysis of Four Phase 3 Trials / Adsit, Sandra (TCR Medical Corporation, San Diego, USA) ; Zaldivar, Enrique Rivas (Dermos, Guatemala) ; Sofen, Howard (UCLA School of Medicine, Los Angeles, USA) ; Dei-Cas, Ignacio (Halitus, Buenos Aires, Argentina) ; Maldonado-García, César (Centro Dermatológico "Dr. Ladislao de la Pascua", Mexico) ; Peñaranda, Elkin O. (Riesgo de Fractura S.A., Bogota, Colombia) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Meng, Xiangyi (Novartis Pharmaceuticals Corporation, East Hanover, USA) ; Fox, Todd (Novartis Pharma AG, Basel, Switzerland) ; Guana, Adriana (Novartis Pharmaceuticals Corporation, East Hanover, USA) ; Universitat Autònoma de Barcelona
There is little evidence available on the efficacy and safety of biologic therapies for the treatment of psoriasis in Hispanic patients. Secukinumab is demonstrated to be highly effective for clearing psoriasis. [...]
2017 - 10.1007/s12325-017-0521-z
Advances in Therapy, Vol. 34 (april 2017) , p. 1327-1339  
Detailed record - Creative Commons

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.
UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with